NYSE:HNGE Hinge Health (HNGE) Stock Price, News & Analysis $67.33 +0.29 (+0.44%) As of 12:09 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Hinge Health Stock (NYSE:HNGE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Hinge Health alerts:Sign Up Key Stats Today's Range$65.96▼$68.0950-Day Range$35.39▼$68.5452-Week Range$30.08▼$70.72Volume237,939 shsAverage Volume1.35 million shsMarket Capitalization$5.22 billionP/E RatioN/ADividend YieldN/APrice Target$75.13Consensus RatingModerate Buy Company Overview Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions. Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs. Participants gain access to on-demand exercise regimens, progress tracking via connected sensors and remote clinician support—all designed to address conditions ranging from back and joint pain to post-surgical rehabilitation. The platform also leverages data analytics and outcomes measurement to continually refine its care pathways and demonstrate value to its clients. Hinge Health has built a leadership team rooted in digital health, physical therapy and behavioral science, led by co-founder and CEO Daniel Perez. Through collaborations with major corporations, insurers and provider networks, the company is expanding its reach across the United States and into select international markets. By simplifying access to high-quality MSK care, Hinge Health seeks to transform how organizations manage one of the most prevalent and costly health challenges globally.AI Generated. May Contain Errors. Read More Hinge Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks79th Percentile Overall ScoreHNGE MarketRank™: Hinge Health scored higher than 79% of companies evaluated by MarketBeat, and ranked 275th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingHinge Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.95, and is based on 2 strong buy ratings, 15 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialHinge Health has a consensus price target of $75.13, representing about 11.3% upside from its current price of $67.52.Amount of Analyst CoverageHinge Health has been the subject of 16 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Hinge Health's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth31.58% Earnings GrowthEarnings for Hinge Health are expected to grow by 31.58% in the coming year, from $1.33 to $1.75 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hinge Health is -5.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hinge Health is -5.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHinge Health has a P/B Ratio of 29.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.45% of the float of Hinge Health has been sold short.Short Interest Ratio / Days to CoverHinge Health has a short interest ratio ("days to cover") of 3.06, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hinge Health has recently decreased by 3.88%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHinge Health does not currently pay a dividend.Dividend GrowthHinge Health does not have a long track record of dividend growth. News and Social Media4.2 / 5News Sentiment0.72 News SentimentHinge Health has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Hinge Health this week, compared to 3 articles on an average week.Search Interest7 people have searched for HNGE on MarketBeat in the last 30 days. This is an increase of 75% compared to the previous 30 days.MarketBeat Follows3 people have added Hinge Health to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Hinge Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $29,859,068.00 in company stock.Percentage Held by Insiders18.92% of the stock of Hinge Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsHinge Health has minimal institutional ownership at this time.Read more about Hinge Health's insider trading history. Receive HNGE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hinge Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HNGE Stock News HeadlinesHinge Health (HNGE) Stock Valuation Split Between Bearish Narrative And Optimistic Cash Flow OutlookJune 14, 2026 | finance.yahoo.comIs Hinge Health a Stock to Sell After an Insider Sold 50,000 Shares?June 14, 2026 | fool.comBUY THIS: Claim a backdoor stake in SpaceXMarc Chaikin, the Wall Street veteran who spotted Nvidia before a 45,000% run, says there's a simple trade available in your brokerage account today that offers backdoor pre-IPO exposure to SpaceX. With the IPO date approaching, Chaikin believes this position could benefit from as high as a $122 billion windfall on IPO day - and he warns against buying in on day one due to potential price instability.June 18 at 1:00 AM | Chaikin Analytics (Ad)Hinge Health, Inc. (HNGE) Analyst/Investor Day - SlideshowJune 13, 2026 | seekingalpha.comHinge Health (NYSE:HNGE) and iRhythm Technologies (NASDAQ:IRTC) Head-To-Head AnalysisJune 13, 2026 | americanbankingnews.comHinge Health (NYSE:HNGE) Chairman Gabriel M.I. Mecklenburg Sells 83,334 SharesJune 4, 2026 | insidertrades.comJames Budge Sells 5,907 Shares of Hinge Health (NYSE:HNGE) StockMay 28, 2026 | insidertrades.comJames Budge Sells 781 Shares of Hinge Health (NYSE:HNGE) StockMay 22, 2026 | insidertrades.comSee More Headlines HNGE Stock Analysis - Frequently Asked Questions How have HNGE shares performed this year? Hinge Health's stock was trading at $46.42 at the start of the year. Since then, HNGE shares have increased by 45.5% and is now trading at $67.5210. How were Hinge Health's earnings last quarter? Hinge Health Inc. (NYSE:HNGE) posted its quarterly earnings results on Tuesday, May, 5th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.33. The company's quarterly revenue was up 47.2% compared to the same quarter last year. Read the conference call transcript. How will Hinge Health's stock buyback program work? Hinge Health's Board of Directors approved a share repurchase program on Wednesday, November 12th 2025, which permits the company to buy back $250,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 7.2% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's board of directors believes its shares are undervalued. When did Hinge Health IPO? Hinge Health (HNGE) raised $410 million in an IPO on Thursday, May 22nd 2025. The company issued 13,666,000 shares at $28.00-$32.00 per share. Who are Hinge Health's major shareholders? Top institutional investors of Hinge Health include Arrowstreet Capital Limited Partnership (1.48%), Bank of America Corp DE (0.80%), Estuary Capital Management LP (0.51%) and Emerald Advisers LLC (0.35%). Insiders that own company stock include Bessemer Venture Partners X L, James Pursley, James Budge, Gabriel MI Mecklenburg, Daniel Antonio Perez, Kristina M Leslie and Insight Holdings Group, Llc. View institutional ownership trends. How do I buy shares of Hinge Health? Shares of HNGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/05/2026Today6/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 For the last 3 weeks, HNGE's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MEDICAL INFO SYS Sub-IndustryBusiness Services Current SymbolNYSE:HNGE Previous SymbolNYSE:HNGE CIK1673743 WebN/A Phone(415) 689-8429FaxN/AEmployees1,437Year Founded2014Price Target and Rating Average Price Target for Hinge Health$75.13 High Price Target$95.00 Low Price Target$45.00 Potential Upside/Downside+11.1%Consensus RatingModerate Buy Rating Score (0-4)2.95 Research Coverage19 Analysts Profitability EPS (Trailing Twelve Months)($12.34) Trailing P/E RatioN/A Forward P/E Ratio50.83 P/E GrowthN/ANet Income-$528.26 million Net Margins-78.95% Pretax Margin-78.82% Return on Equity-310.62% Return on Assets-71.08% Debt Debt-to-Equity RatioN/A Current Ratio1.30 Quick Ratio1.27 Sales & Book Value Annual Sales$587.86 million Price / Sales8.90 Cash FlowN/A Price / Cash FlowN/A Book Value$2.26 per share Price / Book29.92Miscellaneous Outstanding Shares77,380,000Free Float62,740,000Market Cap$5.23 billion OptionableN/A BetaN/A Social Links 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NYSE:HNGE) was last updated on 6/18/2026 by MarketBeat.com Staff. From Our PartnersUSAU Breakout Setup: $27 in Focus!U.S. Gold Corp. (NASDAQ: USAU) is drawing serious Wall Street attention around its fully permitted CK Gold Pro...Huge Alerts | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...Decentralized Masters | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrade the fastest names including SpaceX --- for 5 days freeFor only the second time this year, ex-institutional trader JR Romero is opening Momentum Express to the publi...T3 Live | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredRead this before you touch SPCXSPCX is live on Nasdaq - but a market expert who called AMD before it climbed as high as 7,100% says buying th...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hinge Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hinge Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
